| Filed On | Filing |
|---|---|
| 17 Jun 2024 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Trawsfynydd Therapeutics, Inc. (the “Company”) as of December 31, 2023 and 2022, and the related statements of operations, redeemable convertible preferred stock and stockholders’ defici... |
| 05 Aug 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 04 Mar 2021 | 8-K/A: Submission of Matters to a Vote of Security Holders; Other Events |
Loading...
